A primary lung cancer patient who underwent lobectomy after one month of dual antiplatelet therapy following coronary stent deployment

The recent development of a new coronal stent and technical advancements in antiplatelet therapy have demonstrated the effectiveness of shortening the period of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI), thus making it possible to perform surgery sooner than had previously been possible. We herein report our efforts to reduce the period for postponing surgery for lung cancer, and thus making it possible to perform surgery as early as one month after coronal stent deployment.A 77-year-old man was incidentally found to have a nodule lesion of primary lung cancer on computed tomography coronary angiography, which led to a diagnosis of silent myocardial ischemia. The patient underwent video-assisted thoracoscopic lobectomy while the preoperative administration of aspirin was continued following one month of DAPT after coronal drug-eluting stent deployment in the proximal portion of the left coronary artery. Pathological and histopathologic examinations revealed the nodule to be stage IB, pT2aN0M0 acinar adenocarcinoma. No growth of lung cancer has been observed on CT since the patient was admitted to our department.